SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the December 2024 quarter is pegged at Rs. 1.99 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2024 is Rs. -4.97 millions as compared to Net Profit of Rs. 0.30 millions of corresponding quarter ended December 2023Operating profit Margin for the quarter ended December 2024 slipped to -4.95% as compared to 0.40% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1.99 0.00 0.00 4.74 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.50 0.00 0.30 1.00 -70.00 1.99 4.19 -52.51
PBIDT -4.95 0.40 -1337.50 -7.85 0.34 -2408.82 0.95 2.34 -59.40
Interest 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
PBDT -4.95 0.40 -1337.50 -7.86 0.34 -2411.76 0.95 2.34 -59.40
Depreciation 0.02 0.02 0.00 0.06 0.06 0.00 0.07 0.08 -12.50
PBT -4.97 0.38 -1407.89 -7.92 0.28 -2928.57 0.88 2.26 -61.06
TAX 0.00 0.08 -100.00 0.00 0.08 -100.00 0.22 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -4.97 0.30 -1756.67 -7.92 0.20 -4060.00 0.66 2.26 -70.80
Equity 52.39 52.39 0.00 52.39 52.39 0.00 52.39 52.39 0.00
PBIDTM(%) -248.74 0.00 0.00 -165.61 0.00 0.00 0.00 0.00 0.00

Venmax Drugs&Pharma Share Price

26.05 1.39 (5.64%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×